ISSN:
1437-7772
Keywords:
Key words p53
;
Lymph node metastasis
;
Colorectal cancer
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Background. Lymph node metastasis has been recognized as the most reliable prognostic factor for colorectal cancer. Of late, the clinical significance of p53 as a prognostic factor has been reported. The purpose of the current study was to elucidate the significance of these two factors in combination as a prognostic indicator for colorectal cancer. Methods. One hundred forty-four patients with colorectal cancer were examined. The expression of p53 was determined by immunohistochemical staining. Patient data, lymph node metastasis, p53 expression, recurrence rate, 5-year survival, and disease-free survival were studied. Results. The recurrence rate for patients with p53− and n1 in combination was 21%, and that for patients with p53+ and n1 in combination was 63%, a significant difference. The 5-year survival rate for patients with p53− and n1 in combination was not significantly different from that for patients with p53+ and n1 in combination (78.7% vs. 57.5%); however, the 5-year disease-free survival rate for patients with p53− and n1 in combination was significantly better than that for patients with p53+ and n1 in combination (78.6% vs. 38.2%). Conclusion. The combination criterion of lymph node metastasis and p53 expression should be a useful prognosticator for colorectal cancer.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s101470050068
Permalink
